Showing results (1061-1070 of 1,366) with videos related to
Sort By:
Pageof 137
Cancer Medicine|January 14, 2026
The Effects of Bone-Remodeling Therapy on Survival, Pain, and Skeletal Related Events in the Setting of Renal Cell Carcinoma With Bone Metastases: A Multicenter Investigation From a Large Global Health Research Network (TriNetX)Brian H Im, Kevin K Zarrabi, Aaron R Hochberg, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 17, 2013
B cell-specific deficiencies in mTOR limit humoral immune responsesShuling Zhang, Margaret Pruitt, Dena Tran, et al.Cancer Research|June 24, 2010
Metastatic growth from dormant cells induced by a col-I-enriched fibrotic environmentDalit Barkan, Lara H El Touny, Aleksandra M Michalowski, et al.The Journal of Clinical Investigation|November 13, 2012
Pathway-specific dopaminergic deficits in a mouse model of Angelman syndromeThorfinn T Riday, Elyse C Dankoski, Michael C Krouse, et al.Neurosurgery|September 28, 2010
Qualitative imaging of adeno-associated virus serotype 2-human aromatic L-amino acid decarboxylase gene therapy in a phase I study for the treatment of Parkinson diseaseFrancisco Valles, Massimo S Fiandaca, Jamie L Eberling, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 9, 2004
Outcomes of acute rejection after interferon therapy in liver transplant recipientsSammy Saab, Denise Kalmaz, Nupoor A Gajjar, et al.Frontiers in Oncology|November 28, 2024
Tumor seeding across specialties: a systematic reviewPavel Kipnis, Diya Ramanathan, Richard Hoehn, et al.Vaccine|August 22, 2018
Safety and immunogenicity of a plant-produced Pfs25 virus-like particle as a transmission blocking vaccine against malaria: A Phase 1 dose-escalation study in healthy adultsJessica A Chichester, Brian J Green, R Mark Jones, et al.Molecular Cancer Therapeutics|September 18, 2020
Efficacy, Tolerability, and Pharmacokinetics of Combined Targeted MEK and Dual mTORC1/2 Inhibition in a Preclinical Model of Mucosal MelanomaBih-Rong Wei, Shelley B Hoover, Cody J Peer, et al.Human Vaccines & Immunotherapeutics|April 24, 2015
Expression, purification, and characterization of the Necator americanus aspartic protease-1 (Na-APR-1 (M74)) antigen, a component of the bivalent human hookworm vaccineChristopher A Seid, Elena Curti, R Mark Jones, et al.Pageof 137